5 - ACS Part 2 Flashcards

1
Q

What is DAPT?

A

dual anti platelet therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 options for treating a STEMI?

A

1) fibrinolytics

2) primary PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 options for treating a UA/NSTEMI?

A

**assess risks
THEN either:

1) early invasive strategy (surgery)
2) ischemia guided strategy (medicine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the initial treatment once ACS is suspected but we don’t know which type (UA, STEMI or NSTEMI)?

A

MONA

  • morphine
  • oxygen
  • nitrates
  • ASA 325 mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe what points are given for to determine a patient’s TIMI Risk Score

A

1 point is given for each of the following:

  • > 65 yo
  • > 3 risk factors for CAD
  • prior coronary stenosis > 50%
  • ST deviation on ECG
  • > 2 anginal events in prior 24 hours
  • use of aspirin in prior 7 days
  • elevated cardiac biomarkers

**see slide 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If they have a TIMI score >2, what should happen?

A

they should be considered for early invasive strategy (surgery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If they have a TIMI score of 0 or 1, what should happen?

A

they would be considered for ischemia guided strategy (medicine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is entailed in early invasive strategy?

A
  • Angiography +/- revascularization (PCI) within 24 hours

- Indicated for high risk patients (TIMI risk score > 2, or presence or other high risk characteristics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is entailed in ischemia-guided strategy?

A
  • medical management
  • patients with low risk features
  • may be referred for revascularization if schema worsens or if new high risk features occur
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Who is a CABG indicated for?

A

-high risk patients with multi vessel disease may be referred for CABG (hold DAPT 5-7 days prior to surgery if possible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antiplatelets:

Options?

A

ASA
Ticagrelor
Clopidogrel
Prasugrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ASA:

Initial dose

A

160-325 mg STAT (chewed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ASA:

Maintenance dose

A

80-325 mg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ticagrelor:

Initial dose

A

180 mg LD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ticagrelor:

Maintenance dose

A

90 mg BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clopidogrel:

Initial dose

A

150-300 mg LD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clopidogrel:

Maintenance dose

A

75 mg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Prasugrel:

Initial dose

A

60 mg LD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Prasugrel:

Maintenance dose

A

10 mg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Who is DAPT indicated for?

A
  • UA/NSTEMI patients who underwent early invasive strategy with PCI should receive DAPT as outlined for STEMI patients
  • For patients with ischemia-guided strategy (medical management), current guidelines recommend DAPT with ASA plus ticagrelor or clopidogrel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How long is DAPT indicated for?

A

for 1 year in all ACS patients whether they are treated medically, with PCI or CABG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MOA of GP 2b/3a inhibitors

A

block binding of fibrinogen to GP 2b/3a receptor on platelet surface, therefore inhibit platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are examples of GP 2b/3a inhibitors

A
  • abciximab
  • eptifibatide
  • tirofiban
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the dose of enoxaparin?

A

1mg/kg SC Q12H (max 100 mg) until PCI or hospital discharge shown to decrease risk of death, MI and stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Advantage of enoxaparin?
easier to give, no monitoring, lower incidence of HIT ?, similar cost to UFH
26
Dose of UFH?
60 units/kg LD then 12 units/kg/hr infusion - titrate to APTT 1.2-2x control - until PCI or 48 hrs
27
What is the standard heparin?
LMWH = standard *if it's someone who is morbidly obese and we can't dose properly or they are known to have chronic failure - switch to UFH
28
Describe fondaparinux
indirect-acting factor Xa inhibitor
29
Dose of Fondaparinux?
2.5mg SC once daily (until PCI or hospital discharge)
30
What advantage does fondaparinux have over enoxparin?
lower rate of major bleeding
31
Goals of adjunct therapy
- reduce the risk of short term and long term complications associated with ACS - slow progression of coronary heart disease and minimize the risk of future cardiovascular events and other morbidities - improve mortality and restore QOL
32
List 4 ACS complications
- heart failure - cardiogenic shock - arrhythmias - pericarditis
33
Describe how heart failure could occur after an ACS
LV myocardium may be ischemic, stunned, hibernating or irrevocably injured after MI
34
Describe how cardiogenic shock could occur after an ACS
- Decreased cardiac output & evidence of tissue hypoxia in presence of adequate intravascular volume - Often due to extensive LV infarction
35
Describe how arrhythmias could occur after an ACS
-arrhythmias may occur post MI due to ischemia and severe HF
36
Describe pericarditis after an ACS
- uncommon and usually presents within 72 hour post MI | - symptoms usually resolve within 3-4 days
37
What is the treatment for pericarditis?
ASA 650 mg po QID or NSAIDs
38
Why are BB used in ACS?
- prevent extension of infarction by reducing oxygen demand | - decrease cardiovascular mortality, recurrent nonfatal MI and all-cause mortality
39
When should BB be initiated after an MI?
within 24 hours after onset of MI unless contraindicated
40
BB: | Start at low dose and titrate to maintain resting HR of ____ bpm
55-60
41
What conditions would make someone contraindicated to get a BB?
- hypotension - bradycardia - acute heart failure - cardiogenic shock - asthma - 2nd or 3rd degree AV block
42
Metoprolol: | Initial dose
25mg BID
43
Metoprolol: | Max dose
100mg BID
44
Atenolol: | Initial dose
12.5-25 mg daily
45
Atenolol: | Max dose
100 mg daily
46
Carvedilol: | Initial dose
3.125 mg BID
47
Carvedilol: | Max dose
25 mg BID
48
Why are ACEi used in ACS?
-minimize ventricular remodelling, reduce oxygen demand and myocardial wall stress by reducing after load or preload
49
When should someone start an ACEi after MI?
within 24 hour of MI once BP has been stabilized unless CI
50
What types of patients should we use ACEi with caution?
those with renal impairment and hyperkalemia
51
What do we monitor for BB?
- BP - HR - signs/symptoms of HF
52
What do we monitor for ACEi?
- SCr - electrolytes - watch for hyperkalemia (K > 5.5)
53
Ramipril: | Initial dose
1.25 - 2.5 mg daily
54
Ramipril: | Target dose
10mg/day
55
Enalapril: | Initial dose
2.5mg BID
56
Enalapril: | Target dose
10-20 mg BID
57
Lisinopril: | Initial dose
2.5-5 mg daily
58
Lisinopril: | Target dose
40 mg daily
59
Captopril: | Initial dose
6.25 TID
60
Captopril: | Target dose
25-50 mg TID
61
Who are ARBs indicated for?
People who cannot tolerate ACEi
62
Monitoring of an ARB is the same as an ____
ACEi
63
Candesartan: | Initial dose
4 mg daily
64
Candesartan: | Target dose
32 mg daily
65
Telmisartan: | Initial dose
40 mg daily
66
Telmisartan: | Target dose
80 mg daily
67
Valsartan: | Initial dose
20 mg BID
68
Valsartan: | Target dose
160 mg BID
69
Statins: If not at max dose already, titrate to achieve _____% reduction in LDL
50-60
70
Monitoring for statins?
- Lipid panel (LDL-C, chol, HDL-C) - LFTs - CK - signs and symptoms of myopathy and rhabdomyolysis
71
Atorvastatin doses
20-80 mg daily
72
Fluvastatin doses
20-80 mg daily
73
Pravastatin doses
20-40 mg daily
74
Lovastatin doses
20-80 mg daily
75
Simvastatin doses
20-80 mg daily
76
Rosuvastatin doses
5-40 mg daily
77
What types of patients should get an MRA (mineralocorticoid receptor antagonist)?
for consideration in patients with significant LV dysfunction (EF < 40%)
78
Should caution MRAs in what types of patients?
CrCl < 30 | K > 5
79
When should K+ be monitored when on an MRA
at baseline and then within 1 week of initiation
80
Spironolactone: | Initial dose
12.5 mg daily
81
Spironolactone: | Target dose
25 mg daily
82
Eplerenone: | Initial dose
25 mg daily
83
Eplerenone: | Target dose
50 mg daily
84
What are some modifiable CHD risk factors?
- smoking cessation - hypertension - dyslipidemia - obesity - sedentary lifestyle - stress
85
List some non-pharm therapies
- weight management - physical exercise - smoking cessation - ICD (implantable cardioverter defibrillator) - stress management/depression screening
86
Goals for weight management?
- BMI 18.5 - 25 - Waist circumference (<100 cm males & < 90 cm in females) - Goal of 5-10% weight reduction
87
Goals for exercise?
30-60 mins of moderate-vigorous physical exercise 3-5x per week *This may change based on each individual's starting exercise habits
88
How much does smoking cessation lower risk of recurrent MI after 2 years?
by half !!!!
89
Are omega 3 fatty acids beneficial for preventing cardiovascular disease?
No evidence, but don't tell patients to stop taking them
90
Are antioxidants such as vitamins A, C, E and beta carotene beneficial for preventing cardiovascular disease?
No
91
How about folic acid with/without vitamin B6 of B12? Is it good for preventing cardiovascular disease?
NOPE
92
Why is hormonal therapy not indicated in post menopausal women post MI?
may increase CV risk
93
Post MI patients need to avoid _____
NSAIDs, including selective COX2 inhibitors
94
Post MI: For active, ongoing users of cocaine and meth, ____ ________ should be avoided due to risk of potentiating coronary spasm
beta blockers